Home Biosimilar Antibodies Angiogenesis FGFR antibody Vofatamab (Anti-FGFR3 / CD333) For research use only.
Not for use in humans.

Vofatamab (Anti-FGFR3 / CD333)

Synonyms: B-701; MFGR-1877S; RG-7444

Vofatamab (Anti-FGFR3 / CD333) is a monoclonal antibody targeting FGFR3. Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC). MW: 145.5 KD.

Vofatamab (Anti-FGFR3 / CD333)

Purity & Quality Control

Batch: A249501 Purity: 99% Protein concentration: 3.09mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective FGFR Inhibitors

Biological Activity

Description Vofatamab (Anti-FGFR3 / CD333) is a monoclonal antibody targeting FGFR3. Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC). MW: 145.5 KD.

Product Details

CAS No. 1312305-12-6
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vofatamab (Anti-FGFR3 / CD333) | Vofatamab (Anti-FGFR3 / CD333) supplier | purchase Vofatamab (Anti-FGFR3 / CD333) | Vofatamab (Anti-FGFR3 / CD333) cost | Vofatamab (Anti-FGFR3 / CD333) manufacturer | order Vofatamab (Anti-FGFR3 / CD333) | Vofatamab (Anti-FGFR3 / CD333) distributor